Published in Vaccine on March 18, 2005
Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med (2006) 1.38
Strategies for cancer vaccine development. J Biomed Biotechnol (2010) 1.26
Colorectal cancer and immunity: what we know and perspectives. World J Gastroenterol (2014) 1.00
Clinical outcomes of active specific immunotherapy in advanced colorectal cancer and suspected minimal residual colorectal cancer: a meta-analysis and system review. J Transl Med (2011) 0.97
Immunological monitoring of anticancer vaccines in clinical trials. Oncoimmunology (2013) 0.95
Clinical evaluation of therapeutic cancer vaccines. Hum Vaccin Immunother (2013) 0.93
Photodynamic therapy-generated vaccines: relevance of tumour cell death expression. Br J Cancer (2007) 0.92
Immunotherapy for gastrointestinal malignancies. Cancer Control (2013) 0.90
Challenges in the development of an autologous heat shock protein based anti-tumor vaccine. Hum Vaccin Immunother (2012) 0.88
Poxviral vectors for cancer immunotherapy. Expert Opin Biol Ther (2012) 0.88
Colorectal cancer immunotherapy. Discov Med (2013) 0.87
Insight to drug delivery aspects for colorectal cancer. World J Gastroenterol (2016) 0.86
Natural killer cell cytokine response to M. bovis BCG Is associated with inhibited proliferation, increased apoptosis and ultimate depletion of NKp44(+)CD56(bright) cells. PLoS One (2013) 0.83
Emerging cancer vaccines: the promise of genetic vectors. Cancers (Basel) (2011) 0.81
Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy. Small (2015) 0.80
Phase I/II study of adjuvant immunotherapy with sentinel lymph node T lymphocytes in patients with colorectal cancer. Cancer Immunol Immunother (2015) 0.79
A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer. Ann Surg Oncol (2014) 0.78
A recombinant adenovirus vector encoding the light chain of human coagulation factor VII and IgG1 Fc fragment to targeting tissue factor for colorectal cancer immunotherapy in the mouse model. J Cancer Res Clin Oncol (2013) 0.77
Is cancer vaccination feasible at older age? Exp Gerontol (2014) 0.77
Prophylactic Antitumor Effect of Mixed Heat Shock Proteins/Peptides in Mouse Sarcoma. Chin Med J (Engl) (2015) 0.76
Immunotherapy in human colorectal cancer: Challenges and prospective. World J Gastroenterol (2016) 0.75
Protective antitumor immunity induced by tumor cell lysates conjugated with diphtheria toxin and adjuvant epitope in mouse breast tumor models. Chin J Cancer (2012) 0.75
Current status of autologous breast tumor cell-based vaccines. Expert Rev Vaccines (2014) 0.75
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
Empirical evidence of design-related bias in studies of diagnostic tests. JAMA (1999) 12.96
Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst (2001) 4.27
Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med (1999) 3.76
Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet (2001) 3.39
Test-retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med (1994) 3.31
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet (1999) 3.25
Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health (1994) 3.10
A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med (2000) 2.92
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology (2008) 2.87
Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst (2009) 2.83
The drug resistance-related protein LRP is the human major vault protein. Nat Med (1995) 2.78
Comparative assessment of pediatric intensive care: a national multicenter study. Pediatric Intensive Care Assessment of Outcome (PICASSO) Study Group. Crit Care Med (1995) 2.78
Reversible thyroid dysfunction during treatment with GM-CSF. Lancet (1991) 2.77
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci U S A (1994) 2.71
Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J Antimicrob Chemother (2007) 2.62
Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors. J Clin Oncol (2000) 2.60
Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial. J Clin Oncol (1993) 2.50
Doxorubicin gradients in human breast cancer. Clin Cancer Res (1999) 2.36
Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33
Autogenous immunity to endogenous RNA tumor virus. Radioimmune precipitation assay of mouse serum antibody levels. J Exp Med (1973) 2.31
Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer (2002) 2.25
Localization of 125I-labeled antigen in germinal centers of mouse spleen: histologic and ultrastructural autoradiographic studies of the secondary immune reaction. J Immunol (1968) 2.21
Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients [seecomments]. Ann Oncol (1997) 2.17
The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain (2005) 2.17
Penile cancer: epidemiology, pathogenesis and prevention. World J Urol (2008) 2.14
Preoperative prediction of severe postoperative pain. Pain (2003) 2.11
Autogenous immunity to endogenous RNA tumor virus. Identification of antibody reactivity to select viral antigens. J Exp Med (1974) 2.10
Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic. Sex Transm Infect (2002) 2.05
Nuchal translucency screening and anxiety levels in pregnancy and puerperium. Ultrasound Obstet Gynecol (2006) 2.03
Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol (2006) 2.02
Economic evaluation of the administration of follitropin-beta with a pen device. Reprod Biomed Online (2005) 1.99
Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup. J Natl Cancer Inst (2000) 1.99
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta (2002) 1.98
Neurological channelopathies. Postgrad Med J (2005) 1.98
[Class substitution as an instrument of efficiency in the supply of medicines: possibilities and limitations]. Ned Tijdschr Geneeskd (2002) 1.97
European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion. J Clin Oncol (1994) 1.97
[Possibilities for anonymous follow-up studies of patients in Dutch national medical registrations using the Municipal Population Register: a pilot study]. Ned Tijdschr Geneeskd (2003) 1.94
Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol (2001) 1.94
Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain (2007) 1.91
Novel empirical disability weights to assess the burden of non-fatal injury. Inj Prev (2008) 1.90
The ultrastructure of antigen localization and viruslike particles in mouse spleen germinal centers. Exp Mol Pathol (1968) 1.86
A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer. Ann Oncol (2004) 1.85
A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain (1999) 1.84
Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer (2006) 1.83
Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer (2002) 1.83
Papillomavirus infection in rural women in southern India. Br J Cancer (2005) 1.79
Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group. Br J Cancer (1994) 1.79
Electron microscopic autoradiography of germinal center cells in mouse spleen. J Cell Biol (1965) 1.78
Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing. Eur J Cancer (1991) 1.77
Increased adverse perinatal outcome of hospital delivery at night. BJOG (2010) 1.77
The effect of adding a cognitive dimension to the EuroQol multiattribute health-status classification system. J Clin Epidemiol (1999) 1.77
Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion (2008) 1.75
Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res (1997) 1.74
Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Ther (1990) 1.73
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res (1999) 1.72
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) (2003) 1.71
Hypoglycaemia associated with the production of insulin-like growth factor II and insulin-like growth factor binding protein 6 by a haemangiopericytoma. Clin Endocrinol (Oxf) (1999) 1.70
Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol (2009) 1.68
Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agent. Ann Oncol (1992) 1.68
The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. Brain (2009) 1.65
Paclitaxel-induced neuropathy. Ann Oncol (1995) 1.65
Reliability and validity of the child health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population. Qual Life Res (2002) 1.64
Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol (2000) 1.64
Late start of antenatal care among ethnic minorities in a large cohort of pregnant women. BJOG (2007) 1.64
CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol (2004) 1.63
Taxanes: a new class of antitumor agents. Cancer Invest (1995) 1.62
Human papillomavirus infection in Shenyang City, People's Republic of China: A population-based study. Br J Cancer (2006) 1.62
Quantification of the level descriptors for the standard EQ-5D three-level system and a five-level version according to two methods. Qual Life Res (2008) 1.60
Apoptosis in myocardial ischaemia and infarction. J Clin Pathol (2002) 1.59
Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins. Neurology (2010) 1.59
Clinical relevance of diagnosing structural chromosome abnormalities in couples with repeated miscarriage. Hum Reprod (2004) 1.57
The taxoids. Comparative clinical pharmacology and therapeutic potential. Drugs (1998) 1.56
The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol (2004) 1.55
A catalyst for change: the European cancer Patient's Bill of Rights. Oncologist (2014) 1.55
Preclinical phase II studies in human tumor lines: a European multicenter study. Eur J Cancer Clin Oncol (1988) 1.54
HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications. Br J Cancer (2012) 1.53
Genetic knowledge and counselling skills of Dutch cardiologists: sufficient for the genomics era? Eur Heart J (2003) 1.52
Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients. J Clin Oncol (1993) 1.51
Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines. Br J Cancer (1999) 1.50
C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion. Eur J Clin Invest (2004) 1.50
Mechanism of action of antitumor drug etoposide: a review. J Natl Cancer Inst (1988) 1.50
HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer (2009) 1.50
Polypeptides of mammalian oncornaviruses. III. Localization of p 15 and reactivity with natural antibody. Virology (1975) 1.48
Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis. J Natl Cancer Inst (1972) 1.48
Increasing maternal age at first pregnancy planning: health outcomes and associated costs. J Epidemiol Community Health (2010) 1.48
Clinical validation of the cobas 4800 HPV test for cervical screening purposes. J Clin Microbiol (2011) 1.47
Does lung transplantation prolong life? A comparison of survival with and without transplantation. J Heart Lung Transplant (1998) 1.47
Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis. J Natl Cancer Inst (1972) 1.47